UCB's Global Corporate Website
Welcome to UCB in the United States

Dec

13

Employee Spotlight: Leah VanderVeen and Her Time as a Court Appointed Special Advocate for Foster Children

Dec

09

UCB Announces Positive Phase 3 Studies for Bimekizumab in Hidradenitis Suppurativa

Dec

07

The Lancet Publishes Results from Two Bimekizumab Phase 3 Studies in Psoriatic Arthritis

Dec

01

UCB to present data at the American Epilepsy Society 76th Annual Meeting 2022 supporting a decades-long commitment to transforming epilepsy care

Nov

23

Epilepsia Publishes Interim Results of Open-Label Extension Study of FINTEPLA® (fenfluramine) Oral Solution in Patients with Lennox-Gastaut Syndrome (LGS)

Nov

22

UCB Submits Response to FDA Complete Response Letter for Bimekizumab

Nov

21

Nicole Williams’ Has an Impact From Investments to Innovation to Inclusion

Nov

17

Shaping the Future of Psoriatic Arthritis Care in Rural Settings

Nov

14

UCB announces U.S. FDA acceptance of new drug application and EMA MAA validation for zilucoplan for the treatment of generalized myasthenia gravis in adult patients

Nov

11

United for Veterans and our Employees Who Serve

United for Veterans is one of UCB’s Employee Resource Groups (ERGs) focused on veterans and veteran supporters. United for Veterans leverages the combined strength of UCB’s veterans and veteran supporters by encouraging through shared experiences, celebrating veterans’ diversity, inspiring professional development, and honoring veteran communities through servant leadership opportunities while fulfilling our company goals and diversity, equity, and inclusion ambition.